GlassScriptPhysician profile
Sujata Tidd
NPI 1265158679
$1,588.21
in general payments reported to CMS, 2019-2025
14 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $197 · 2023: $508 · 2024: $625 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,229.72 |
| Education | $161.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $497.04 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $321.35 | 2024-2025 | |
| Genzyme Corporation | $256.30 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $128.04 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.16 | 2023-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $48.92 | 2023-2025 | Breztri, Airsupra |
| Axsome Therapeutics, INC. | $47.90 | 2023-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $41.88 | 2025 | Glassia |
| Inspire Medical Systems, INC. | $38.36 | 2023 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $24.01 | 2024 | Lumryz |
| Baxter Healthcare | $23.69 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Sanofi Pasteur INC. | $22.27 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $19.67 | 2024 | Uptravi, Opsumit |
| Lilly USA, LLC | $16.62 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujata Tidd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.